CIK 0001847367
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Srivastava Sapna Director | Grant or award | +3,553 | 3,553 | ||
| 2026-06-30 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2025-07-30 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2024-07-01 | Srivastava Sapna Director | Returned to the company · Stock Option (Right to Buy) | −28,877 | 0 | ||
| 2024-07-01 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +28,877 | 28,877 | ||
| 2024-07-01 | Srivastava Sapna Director | Returned to the company · Stock Option (Right to Buy) | −29,946 | 0 | ||
| 2024-07-01 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +29,946 | 29,946 | ||
| 2024-06-27 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +28,877 | 28,877 |
Page 1 of 1 · 8 trades